|
C1D expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.69464483848969E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.28279958772271E-10 |
| Normal-vs-Stage2 |
5.361500E-04 |
| Normal-vs-Stage3 |
1.60700341922393E-11 |
| Normal-vs-Stage4 |
<1E-12 |
| Stage1-vs-Stage2 |
5.859200E-01 |
| Stage1-vs-Stage3 |
4.327700E-02 |
| Stage1-vs-Stage4 |
1.449310E-04 |
| Stage2-vs-Stage3 |
7.918400E-02 |
| Stage2-vs-Stage4 |
1.914230E-02 |
| Stage3-vs-Stage4 |
6.016600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.22124532708767E-14 |
| Normal-vs-AfricanAmerican |
1.843510E-04 |
| Normal-vs-Asian |
2.877100E-03 |
| Caucasian-vs-AfricanAmerican |
1.497950E-02 |
| Caucasian-vs-Asian |
9.126000E-01 |
| AfricanAmerican-vs-Asian |
3.235800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.4757973449141E-14 |
| Normal-vs-Female |
1.67559965902342E-10 |
| Male-vs-Female |
2.189400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.36979999565412E-08 |
| Normal-vs-Age(41-60Yrs) |
3.54816176439954E-12 |
| Normal-vs-Age(61-80Yrs) |
2.21767049168875E-12 |
| Normal-vs-Age(81-100Yrs) |
7.87600000000666E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.103400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.053600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.056600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.268400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.236000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.154600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.034800E-01 |
| Normal-vs-Grade 2 |
1.03420000341359E-08 |
| Normal-vs-Grade 3 |
1.62458935193399E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
2.242800E-01 |
| Grade 1-vs-Grade 3 |
3.457500E-02 |
| Grade 1-vs-Grade 4 |
4.999200E-03 |
| Grade 2-vs-Grade 3 |
2.883500E-02 |
| Grade 2-vs-Grade 4 |
1.62127999999706E-05 |
| Grade 3-vs-Grade 4 |
1.757190E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.98670000450818E-08 |
| Normal-vs-ccB subtype |
1.62492241884138E-12 |
| ccA subtype-vs-ccB subtype |
2.786600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.06340491967671E-11 |
| Normal-vs-N1 |
2.99190006103345E-10 |
| N0-vs-N1 |
1.123880E-02 |
|
|
